Board Meetings for ALIVUS
Detailed list of historic and upcoming board meetings.
| Symbol | Company | Meeting Date | Purpose | Description | Links |
|---|---|---|---|---|---|
| ALIVUS | Alivus Life Sciences Limited | 14 May 2026 | Financial Results/Dividend | To consider and approve the financial results for the quarter and year ended March 31, 2026 and to consider and recommend dividend, if any, on Equity Shares, for the year ended March 31, 2026. | |
| ALIVUS | Alivus Life Sciences Limited | 14 May 2026 | Board Meeting Intimation | Alivus Life Sciences Limited has informed the Exchange about Board Meeting to be held on 14-May-2026 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2026 and Dividend. | |
| ALIVUS | Alivus Life Sciences Limited | 22 Jan 2026 | Financial Results | A meeting of the Board of Directors will be held on Thursday, January 22, 2026 inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and nine months ended 31st December, 2025. | |
| ALIVUS | Alivus Life Sciences Limited | 22 Jan 2026 | Board Meeting Intimation | Alivus Life Sciences Limited has informed the Exchange about Board Meeting to be held on 22-Jan-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2025 . | |
| ALIVUS | Alivus Life Sciences Limited | 06 Nov 2025 | Board Meeting Intimation | Alivus Life Sciences Limited has informed the Exchange about Board Meeting to be held on 06-Nov-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended September 2025 . | |
| ALIVUS | Alivus Life Sciences Limited | 06 Nov 2025 | Financial Results | To consider and approve the unaudited financial results for the quarter and half year ended September 30, 2025 | |
| ALIVUS | Alivus Life Sciences Limited | 01 Aug 2025 | Board Meeting Intimation | Alivus Life Sciences Limited has informed the Exchange about Board Meeting to be held on 01-Aug-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2025 . | |
| ALIVUS | Alivus Life Sciences Limited | 01 Aug 2025 | Financial Results | inter alia, to consider and approve the financial results for the period ended Jun 30, 2025 | |
| ALIVUS | Alivus Life Sciences Limited | 15 May 2025 | Board Meeting Intimation | Alivus Life Sciences Limited has informed the Exchange about Board Meeting to be held on 15-May-2025 to consider and approve the Yearly Audited Financial results of the Company for the period ended March 2025 and Dividend. | |
| ALIVUS | Alivus Life Sciences Limited | 15 May 2025 | Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2025 and dividend | |
| ALIVUS | Alivus Life Sciences Limited | 23 Jan 2025 | Board Meeting Intimation | Glenmark Life Sciences Limited has informed the Exchange about Board Meeting to be held on 23-Jan-2025 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended December 2024 . | |
| ALIVUS | Alivus Life Sciences Limited | 24 Oct 2024 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 24-Oct-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Half Yearly ended September 2024 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 25 Jul 2024 | Financial Results | To consider and approve the financial results for the period ended Jun 30, 2024 | |
| ALIVUS | Alivus Life Sciences Limited | 25 Jul 2024 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 25-Jul-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Quarterly ended June 2024 . | Board Meeting Intimation | |
| ALIVUS | Alivus Life Sciences Limited | 25 Apr 2024 | GLENMARK LIFE SCIENCES LIMITED has informed the Exchange about Board Meeting to be held on 25-Apr-2024 to inter-alia consider and approve the Audited Financial results of the Company for the Yearly ended March 2024 . | Board Meeting Intimation |
Showing page 1 of 3 (34 total items)